EVM
ALXN

Eaton Vance Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-525,590
Closed -$96.6M 2893
2021
Q2
$96.6M Buy
525,590
+1,619
+0.3% +$297K 0.13% 163
2021
Q1
$80.1M Buy
523,971
+1,053
+0.2% +$161K 0.12% 177
2020
Q4
$81.7M Sell
522,918
-21,057
-4% -$3.29M 0.13% 164
2020
Q3
$62.2M Sell
543,975
-78,207
-13% -$8.95M 0.11% 173
2020
Q2
$69.8M Buy
622,182
+11,013
+2% +$1.24M 0.14% 154
2020
Q1
$54.9M Buy
611,169
+358
+0.1% +$32.1K 0.13% 148
2019
Q4
$66.1M Buy
610,811
+56
+0% +$6.06K 0.13% 163
2019
Q3
$59.8M Sell
610,755
-31,993
-5% -$3.13M 0.13% 163
2019
Q2
$84.2M Buy
642,748
+62,297
+11% +$8.16M 0.18% 122
2019
Q1
$78.5M Sell
580,451
-8,713
-1% -$1.18M 0.18% 130
2018
Q4
$57.4M Sell
589,164
-506,377
-46% -$49.3M 0.15% 146
2018
Q3
$152M Sell
1,095,541
-78,124
-7% -$10.9M 0.34% 88
2018
Q2
$146M Sell
1,173,665
-1,128,531
-49% -$140M 0.35% 83
2018
Q1
$257M Buy
2,302,196
+1,203,600
+110% +$134M 0.32% 90
2017
Q4
$131M Buy
1,098,596
+169,542
+18% +$20.3M 0.32% 88
2017
Q3
$130M Buy
929,054
+91,913
+11% +$12.9M 0.34% 88
2017
Q2
$102M Sell
837,141
-488,132
-37% -$59.4M 0.27% 105
2017
Q1
$161M Buy
1,325,273
+555,689
+72% +$67.4M 0.43% 67
2016
Q4
$94.2M Buy
769,584
+338,722
+79% +$41.4M 0.27% 105
2016
Q3
$52.8M Sell
430,862
-213,016
-33% -$26.1M 0.15% 144
2016
Q2
$75.2M Buy
643,878
+398,784
+163% +$46.6M 0.22% 112
2016
Q1
$34.1M Buy
245,094
+27,835
+13% +$3.88M 0.1% 164
2015
Q4
$41.4M Buy
217,259
+5,294
+2% +$1.01M 0.12% 149
2015
Q3
$33.1M Buy
211,965
+39,181
+23% +$6.13M 0.1% 170
2015
Q2
$31.2M Buy
172,784
+20,562
+14% +$3.72M 0.1% 171
2015
Q1
$26.4M Buy
152,222
+49,995
+49% +$8.66M 0.08% 189
2014
Q4
$18.9M Buy
102,227
+29,890
+41% +$5.53M 0.06% 239
2014
Q3
$12M Buy
72,337
+36,932
+104% +$6.12M 0.04% 286
2014
Q2
$5.53M Buy
35,405
+14,005
+65% +$2.19M 0.02% 374
2014
Q1
$3.26M Buy
21,400
+5
+0% +$761 0.01% 451
2013
Q4
$2.84M Hold
21,395
0.01% 470
2013
Q3
$2.49M Buy
21,395
+2
+0% +$232 0.01% 464
2013
Q2
$1.97M Buy
+21,393
New +$1.97M 0.01% 498